神经病理性疼痛患者血清miR-15a水平及意义分析

doi:10.3877/cma.j.issn.2095-123X.2023.05.006

目的

检测血清微小核糖核酸-15a（miR-15a）在神经病理性疼痛（NP）患者中的表达水平，并分析临床意义。

方法

选取天津医科大学第二医院神经内科自2019年10月至2022年1月收治的115例NP患者作为研究组，另选取同期在本院体检的115例无疼痛且身体健康者作为对照组。采用视觉模拟评分法（VAS）评估研究组患者的疼痛强度；采用焦虑自评量表（SAS）、抑郁自评量表（SDS）评估研究组和对照组的焦虑、抑郁情况；采用实时荧光定量PCR检测研究组和对照组的血清miR-15a表达水平。比较2组受试者的SAS、SDS评分及血清miR-15a表达水平；比较研究组中不同病因患者VAS评分和血清miR-15a表达水平，统计焦虑、抑郁发生情况，并比较有无焦虑、抑郁患者的血清miR-15a表达水平。采用Pearson法分析研究组患者血清miR-15a表达水平与疼痛、焦虑、抑郁程度的关系。

结果

研究组患者焦虑、抑郁的发生率分别为32.17%和51.30%。研究组患者SAS、SDS评分和血清miR-15a表达水平均高于对照组，差异有统计学意义（P<0.05）。研究组中不同病因患者的VAS评分、血清miR-15a表达水平比较，差异有统计学意义（P<0.05）；焦虑、抑郁患者血清miR-15a表达水平均高于无焦虑、无抑郁患者，差异有统计学意义（P<0.05）。血清miR-15a表达水平与VAS、SAS、SDS评分均呈正相关（P<0.05）。

结论

NP患者不仅存在高强度的疼痛，还易并发焦虑和抑郁，其血清miR-15a呈高表达，且血清miR-15a表达水平与疼痛、焦虑、抑郁程度密切相关。

关键词: 神经病理性疼痛, 微小核糖核酸-15a, 焦虑, 抑郁

Objective

To detect the expression level of serum miRNA-15a (miR-15a) in patients with neuropathic pain (NP) and analyze its clinical significancen.

Methods

One hundred and fifteen patients with NP admitted to the Neurology Department of Second Hospital of Tianjin Medical University from October 2019 to January 2022 were selected as the study group, and 115 patients without pain and in good health who underwent physical examination during the same period were selected as the control group. Visual analogue scale (VAS) was used to evaluate the pain intensity of the study group, and self rating anxiety scale (SAS) and self rating depression scale (SDS) were used to evaluate the anxiety and depression of patients in the study group and the control group, and real-time fluorescence quantitative polymerase chain reaction was used to quantitatively detect the expression level of serum miR-15a in the study group and the control group. SAS, SDS scores and serum miR-15a expression levels were compared between the study group and the control group. The VAS scores and serum miR-15a expression levels of patients with different etiologies in the study group were compared. The occurrence of anxiety and depression in the study group was counted, and the expression levels of serum miR-15a were compared between patients with anxiety and depression and patients without anxiety and depression in the study group. Pearson method was used to analyze the relationship between the serum miR-15a expression level and pain, anxiety and depression scores in the study group.

Results

The incidence of anxiety and depression in the study group were 32.17% and 51.30%, respectively. The SAS, SDS scores and serum miR-15a expression levels in the study group were higher than those in the control group (P<0.05). There were statistically significant difference in VAS scores and serum miR-15a expression levels among patients with different etiologies in the study group (P<0.05). The expression levels of serum miR-15a in patients with anxiety and depression in the study group were higher than those in patients without anxiety and depression (P<0.05). The expression level of serum miR-15a in the study group was positively correlated with VAS, SAS and SDS scores (P<0.05).

Conclusion

NP patients not only have high-intensity pain, but also are prone to be complicated with anxiety and depression. Serum miR-15a is highly expressed in NP patients, and the expression level of serum miR-15a is closely related to the degree of pain, anxiety and depression.

Key words: Neuropathic pain, MicroRNA-15a, Anxiety, Depression

表1 2组受试者SAS、SDS评分及血清miR-15a表达水平比较（Mean±SD）

Tab.1 Comparison of SAS scores, SDS scores, and serum miR-15a expression levels between two groups (Mean±SD)

组别	例数	SAS（分）	SDS（分）	miR-15a
研究组	115	46.20±7.89	52.42±14.27	4.76±0.54
对照组	115	32.58±7.64	35.09±8.77	1.00
t值		13.299	12.376	74.669
P值		<0.001	<0.001	<0.001

表1 2组受试者SAS、SDS评分及血清miR-15a表达水平比较（Mean±SD）

Tab.1 Comparison of SAS scores, SDS scores, and serum miR-15a expression levels between two groups (Mean±SD)

组别	例数	SAS（分）	SDS（分）	miR-15a
研究组	115	46.20±7.89	52.42±14.27	4.76±0.54
对照组	115	32.58±7.64	35.09±8.77	1.00
t值		13.299	12.376	74.669
P值		<0.001	<0.001	<0.001

表2 研究组不同病因患者VAS评分、血清miR-15a表达水平比较（Mean±SD）

Tab.2 Comparison SAS scores and serum miR-15a expression levels in patients with different etiologies in the study group (Mean±SD)

病因	例数	VAS（分）	miR-15a
带状疱疹神经痛	59	7.86±0.94	4.96±0.42
三叉神经痛	28	6.38±1.04^a	4.65±0.54^a
坐骨神经痛	10	5.24±0.69^ab	4.16±0.57^ab
脑卒中后神经痛	8	6.40±1.14^ac	4.73±0.52^c
糖尿病性周围神经病变	6	4.50±1.75^abd	4.36±0.74^a
多发性硬化性疼痛	2	5.40±0.42^ad	4.63±0.71
脊髓损伤性疼痛	2	6.80±0.42^ce	4.69±0.47
F值		21.552	4.926
P值		<0.001	<0.001

表2 研究组不同病因患者VAS评分、血清miR-15a表达水平比较（Mean±SD）

Tab.2 Comparison SAS scores and serum miR-15a expression levels in patients with different etiologies in the study group (Mean±SD)

病因	例数	VAS（分）	miR-15a
带状疱疹神经痛	59	7.86±0.94	4.96±0.42
三叉神经痛	28	6.38±1.04^a	4.65±0.54^a
坐骨神经痛	10	5.24±0.69^ab	4.16±0.57^ab
脑卒中后神经痛	8	6.40±1.14^ac	4.73±0.52^c
糖尿病性周围神经病变	6	4.50±1.75^abd	4.36±0.74^a
多发性硬化性疼痛	2	5.40±0.42^ad	4.63±0.71
脊髓损伤性疼痛	2	6.80±0.42^ce	4.69±0.47
F值		21.552	4.926
P值		<0.001	<0.001

图1 研究组血清miR-15a表达水平与VAS、SAS、SDS评分的相关性分析A：血清miR-15a表达水平与VAS评分的相关性；B：血清miR-15a表达水平与SAS评分的相关性；C：血清miR-15a表达水平与SDS评分的相关性；VAS：视觉模拟评分；SAS：焦虑自评量表；SDS：抑郁自评量表

Fig.1 Correlation analysis between serum miR-15a expression level and the scores of VAS, SAS and SDS in the study group

[1]	Bouhassira D. Neuropathic pain: definition, assessment and epidemiology[J]. Rev Neurol (Paris), 2019, 175(1-2): 16-25. DOI: 10.1016/j.neurol.2018.09.016.
[2]	彭绍鹏,刘建雄,王飞,等. PBC治疗三叉神经痛术中球囊压力与术后并发症、复发的关系研究[J].中华神经医学杂志, 2022, 21(2): 152-156. DOI: 10.3760/cma.j.cn115354-20210607-00363.
[3]	江伟,袁良津,唐向阳,等.高频重复经颅磁刺激规律间歇治疗丘脑梗死后中枢性疼痛的临床研究[J].中华脑科疾病与康复杂志(电子版), 2022, 12(5): 269-273. DOI: 10.3877/cma.j.issn.2095-123X.2022.05.003.
[4]	Pan Z, Shan Q, Gu P, et al. miRNA-23a/CXCR4 regulates neuropathic pain via directly targeting TXNIP/NLRP3 inflammasome axis[J]. J Neuroinflammation, 2018, 15(1): 29. DOI: 10.1186/s12974-018-1073-0.
[5]	Wu J, Wang C, Ding H. LncRNA MALAT1 promotes neuropathic pain progression through the miR-1545p/AQP9 axis in CCI rat models[J]. Mol Med Rep, 2020, 21(1): 291-303. DOI: 10.3892/mmr.2019.10829.
[6]	Ye L, Morse LR, Falci SP, et al. hsa-MiR-19a-3p and hsa-MiR-19b-3p are associated with spinal cord injury-induced neuropathic pain: findings from a genome-wide MicroRNA expression profiling screen[J]. Neurotrauma Rep, 2021, 2(1): 424-439. DOI: 10.1089/neur.2021.0011.
[7]	Cai L, Liu X, Guo Q, et al. MiR-15a attenuates peripheral nerve injury-induced neuropathic pain by targeting AKT3 to regulate autophagy[J]. Genes Genomics, 2020, 42(1): 77-85. DOI: 10.1007/s13258-019-00881-z.
[8]	神经病理性疼痛诊疗专家组.神经病理性疼痛诊疗专家共识[J].中国疼痛医学杂志, 2013, 19(12): 705-710. DOI: 10.3969/j.issn.1006-9852.2013.12.001.
[9]	刘娜,李君,冯艺,等.三个中文版神经病理性疼痛诊断量表的制定与多中心验证[J].中国疼痛医学杂志, 2011, 17(9): 549-553. DOI: 10.3969/j.issn.1006-9852.2011.09.011.
[10]	Dunstan DA, Scott N, Todd AK. Screening for anxiety and depression: reassessing the utility of the Zung scales[J]. BMC Psychiatry, 2017, 17(1): 329. DOI: 10.1186/s12888-017-1489-6.
[11]	Scholz J, Finnerup NB, Attal N, et al. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain[J]. Pain, 2019, 160(1): 53-59. DOI: 10.1097/j.pain.0000000000001365.
[12]	张黎.周围神经减压术与周围神经源性疼痛[J].中华神经创伤外科电子杂志, 2023, 9(1): 1-6. DOI: 10.3877/cma.j.issn.2095-9141.2023.01.001.
[13]	Lu Y, Li J, Liu Y. Depression as a mediator of quality of life in patients with neuropathic pain: a cross-sectional study[J]. J Adv Nurs, 2019, 75(11): 2719-2726. DOI: 10.1111/jan.14111.
[14]	Mecca CM, Chao D, Yu G, et al. Dynamic change of endocannabinoid signaling in the medial prefrontal cortex controls the development of depression after neuropathic pain[J]. J Neurosci, 2021, 41(35): 7492-7508. DOI: 10.1523/JNEUROSCI.3135-20.2021.
[15]	廖宇良,杨少敏,陈盼,等.带状疱疹性神经痛病人焦虑抑郁状况调查及皮质醇激素水平变化相关性分析[J].中国疼痛医学杂志, 2020, 26(2): 137-140. DOI: 10.3969/j.issn.1006-9852.2020.02.011.
[16]	Melek LN, Smith JG, Karamat A, et al. Comparison of the neuropathic pain symptoms and psychosocial impacts of trigeminal neuralgia and painful posttraumatic trigeminal neuropathy[J]. J Oral Facial Pain Headache, 2019, 33(1): 77-88. DOI: 10.11607/ofph.2157.
[17]	田润利,郭朝晖,李永男,等.神经病理性疼痛大鼠海马miRNA差异性表达研究[J].现代生物医学进展, 2018, 18(9): 1628-1632. DOI: 10.13241/j.cnki.pmb.2018.09.006.
[18]	Al-Rawaf HA, Alghadir AH, Gabr SA. MicroRNAs as biomarkers of pain intensity in patients with chronic fatigue syndrome[J]. Pain Pract, 2019, 19(8): 848-860. DOI: 10.1111/papr.12817.
[19]	Song G, Yang Z, Guo J, et al. Interactions among lncRNAs/circRNAs, miRNAs, and mRNAs in neuropathic pain[J]. Neurotherapeutics, 2020, 17(3): 917-931. DOI: 10.1007/s13311-020-00881-y.
[20]	李涛. microRNA-15a/16通过G蛋白偶联受体激酶2调节神经性疼痛的机制研究[D].长春:吉林大学, 2020.
[21]	张玉荣,王瑞忠,陈蕊,等.产前应激子代大鼠海马Wnt/β-catenin信号通路的改变诱导抑郁和焦虑样行为[J].南方医科大学学报, 2019, 39(2): 222-226. DOI: 10.12122/j.issn.1673-4254.2019.09.15.
[22]	Wang Q, Miao Y, Qian Z, et al. MicroRNA-15a-5p plays a role in osteogenic MC3T3-E1 cells differentiation by targeting PDCD4 (programmed cell death 4) via Wnt/β-catenin dependent signaling pathway[J]. Bioengineered, 2021, 12(1): 8173-8185. DOI: 10.1080/21655979.2021.1977766.
[23]	Maffioletti E, Bocchio-Chiavetto L, Perusi G, et al. Inflammation-related microRNAs are involved in stressful life events exposure and in trauma-focused psychotherapy in treatment-resistant depressed patients[J]. Eur J Psychotraumatol, 2021, 12(1): 1987655. DOI: 10.1080/20008198.2021.1987655.

[1]	吴晶晶, 胡倩, 李华凤. 围产期焦虑/抑郁与分娩疼痛相关性的研究现状[J]. 中华妇幼临床医学杂志(电子版), 2023, 19(02): 156-161.
[2]	赵宏, 崔红, 宋雪杨, 曾敏敏. 儿童牙科畏惧症的影响因素及其与父母教养方式的相关性研究[J]. 中华口腔医学研究杂志(电子版), 2023, 17(02): 111-117.
[3]	钟轼, 李斌飞, 温君琳, 古晨, 廖小卒. 右美托咪定缓解神经病理性疼痛作用机制的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(03): 237-240.
[4]	王琦, 陈新, 闵捷, 方露, 刘志奇, 孙伟, 于德新. 膀胱软镜镜检术中改良"Bag Squeeze"法的应用与疼痛焦虑影响因素分析[J]. 中华腔镜泌尿外科杂志(电子版), 2023, 17(03): 237-241.
[5]	戴玮, 江桂林, 车兆平, 张姣, 王星星, 赵海涛. 无缝手术护理在腹股沟疝腹腔镜手术围手术期的应用效果[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(06): 778-781.
[6]	向承红, 耿苗苗, 刘亦婷. King达标理论在腹壁巨大切口疝患者术前访视中的应用[J]. 中华疝和腹壁外科杂志(电子版), 2023, 17(01): 109-112.
[7]	张荷连, 刘禹, 李丹妮, 彭茹, 杨彩蝶, 窦恒, 吴红梅. 心理障碍对重度哮喘患者的疾病控制及生活工作质量的影响[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 589-591.
[8]	蒋丽, 王晓慧, 李维益, 苟双芸, 丁敏, 杨丽. 创新智能健康教育与随访管理对肺结节患者焦虑的影响随机对照研究[J]. 中华肺部疾病杂志(电子版), 2023, 16(04): 485-489.
[9]	赵晓红, 修翠萍, 张瑜, 吴珂. 大康复理念在COPD稳定期肺康复治疗的临床应用[J]. 中华肺部疾病杂志(电子版), 2023, 16(03): 424-426.
[10]	陈冀, 邓才霞, 张厚丽, 祝冰晶, 刘攀, 何建, 唐春兰, 周向东, 罗虎. 高危肺结节患者认知及焦虑状况调查分析[J]. 中华肺部疾病杂志(电子版), 2023, 16(02): 164-168.
[11]	吴玥琳, 欧泳琳, 肖海燕, 段业英, 陆翠薇, 李德阳, 王懿春, 唐灏珂. 危重症孕产妇的心理状况及其影响因素的调查[J]. 中华重症医学电子杂志, 2023, 09(02): 198-204.
[12]	潘惠, 王明, 杨忠, 杜向东. 低频重复经颅磁刺激辅助治疗伴不同特征抑郁症的对照研究[J]. 中华临床医师杂志(电子版), 2023, 17(05): 562-568.
[13]	李琼蔚, 苏怡, 卢喆, 李谦, 孙伟. 内蒙古赤峰地区高中生睡眠问题现状调查[J]. 中华临床医师杂志(电子版), 2023, 17(02): 117-124.
[14]	郭梦, 雷蕾, 杨春霞, 孙宁, 张爱霞, 张克让. 抑郁症患者静息态脑电功能连接的研究进展[J]. 中华临床医师杂志(电子版), 2023, 17(02): 210-214.
[15]	文明, 熊英, 艾克拜尔·艾力, 克力木·阿不都热依木. 质子泵抑制剂治疗期间焦虑对胃食管反流病疗效的影响[J]. 中华胃食管反流病电子杂志, 2023, 10(02): 90-95.

阅读次数

全文

摘要

选择文件类型/文献管理软件名称

选择包含的内容

Analysis of serum miR-15a level and significance in patients with neuropathic pain

模态框（Modal）标题

选择文件类型/文献管理软件名称

选择包含的内容

Analysis of serum miR-15a level and significance in patients with neuropathic pain